| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 88.859 | 57.079 | 57.730 | 73.187 | 90.335 | 77.735 | 46.379 | 26.178 | 18.667 | 19.330 |
| Total Income - EUR | 88.959 | 57.079 | 59.257 | 73.909 | 91.917 | 77.735 | 46.390 | 26.350 | 18.667 | 19.330 |
| Total Expenses - EUR | 56.105 | 45.837 | 46.480 | 54.468 | 48.642 | 41.196 | 28.754 | 18.065 | 13.416 | 15.040 |
| Gross Profit/Loss - EUR | 32.854 | 11.242 | 12.776 | 19.441 | 43.275 | 36.539 | 17.636 | 8.285 | 5.251 | 4.290 |
| Net Profit/Loss - EUR | 27.489 | 10.671 | 12.186 | 18.696 | 42.356 | 35.807 | 17.227 | 8.061 | 5.085 | 3.739 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Vanimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.385 | 5.726 | 4.105 | 2.161 | 4.407 | 7.115 | 5.551 | 19.469 | 18.333 | 17.483 |
| Current Assets | 29.918 | 14.400 | 24.145 | 22.527 | 43.785 | 61.865 | 77.486 | 71.406 | 64.773 | 55.581 |
| Inventories | 2.416 | 2.253 | 1.387 | 1.340 | 0 | 81 | 0 | 0 | 2.356 | 0 |
| Receivables | 25.579 | 5.154 | 32 | 4.840 | 3.795 | 14.637 | 12.728 | 11.300 | 33.718 | 16.077 |
| Cash | 1.924 | 6.993 | 22.726 | 16.348 | 39.990 | 47.147 | 64.758 | 60.106 | 28.699 | 39.503 |
| Shareholders Funds | 35.240 | 11.440 | 12.942 | 19.438 | 43.083 | 65.669 | 81.440 | 89.754 | 94.567 | 82.079 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 2.051 |
| Debts | 3.211 | 9.519 | 15.829 | 5.469 | 5.108 | 3.368 | 1.610 | 1.136 | 1.185 | 3.311 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Vanimed S.r.l.